title: Effects of RSV infection on pulmonary surfactant protein SP-A in cultured human type II cells: contrasting consequences on SP-A mRNA and protein.
abstract: Respiratory syncytial virus (RSV) is the most important cause of serious lower respiratory illness in infants and children. Surfactant proteins A (SP-A) and D (SP-D) play critical roles in lung defense against RSV infections. Alterations in surfactant protein homeostasis in the lung may result from changes in production, metabolism, or uptake of the protein within the lung. We hypothesized that RSV infection of the type II cell, the primary source of surfactant protein, may alter surfactant protein gene expression. Human type II cells grown in primary culture possess lamellar bodies (a type II cell-specific organelle) and the ability to express surfactant protein mRNA. These cells were infected with RSV (by morphology and antibody binding). Surfactant protein mRNA levels determined by quantitative RT-PCR indicated a marked increase in SP-A mRNA levels (3-fold) 24 h after RSV exposure, whereas SP-D mRNA levels were unaffected. In contrast to mRNA levels, total SP-A protein levels (determined by Western blot analysis) were decreased 40% after RSV infection. The percentage of secreted SP-A was 43% of the total SP-A in the RSV-infected cells, whereas the percentage of secreted SP-A was 61% of the total SP-A in the uninfected cells. These changes in SP-A transcript levels and protein secretion in cultured human cells were recapitulated in RSV-infected mouse lung. Our findings suggest that type II cells are potentially important targets of RSV lower respiratory infection and that alterations in surfactant protein gene expression and SP-A protein homeostasis in the lung may arise via direct effects of RSV.
authors.affiliation: Dept. of Pediatrics, The University of Texas-Houston Medical School, 6431 Fannin, Suite 3.222, Houston, TX 77030, USA. joseph.l.alcorn@uth.tmc.edu
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Alcorn
authors.forename: James M
authors.initials: JM
authors.lastname: Stark
authors.forename: Constance L
authors.initials: CL
authors.lastname: Chiappetta
authors.forename: Gaye
authors.initials: G
authors.lastname: Jenkins
authors.forename: Giuseppe N
authors.initials: GN
authors.lastname: Colasurdo
mesh_terms: D002478:Cells, Cultured; D002675:Child, Preschool; D015967:Gene Expression Regulation, Viral; D006706:Homeostasis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011650:Pulmonary Alveoli / Q000378:metabolism* / Q000648:ultrastructure / Q000821:virology; D037662:Pulmonary Surfactant-Associated Protein A / Q000096:biosynthesis*; D037663:Pulmonary Surfactant-Associated Protein D / Q000096:biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis*; D018357:Respiratory Syncytial Virus Infections / Q000378:metabolism* / Q000821:virology; D012136:Respiratory Syncytial Viruses; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods
chemical_list: D037662:Pulmonary Surfactant-Associated Protein A; D037663:Pulmonary Surfactant-Associated Protein D; D012333:RNA, Messenger